Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

INST: Phase I-II Study of Carboplatin, Vinorelbine and Capecitabine in Patients With Metastatic Breast Cancer

NCT00277069 is registered in ClinicalTrials.gov with University of New Mexico as lead sponsor.

NCT NCT00277069
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00277069 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
INST: Phase I-II Study of Carboplatin, Vinorelbine and Capecitabine in Patients With Metastatic Breast Cancer
Lead sponsor
University of New Mexico
Phase
Phase 1/2
Overall status
Completed
Start date
May 31, 2000
Completion date
March 31, 2006
Enrollment
33 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast, cancer